Cisen Pharmaceutical Co Ltd Asset Resilience Ratio

Latest as of June 2026: 28.62%

Cisen Pharmaceutical Co Ltd asset resilience ratio. Cisen Pharmaceutical Co Ltd (603367) has an Asset Resilience Ratio of 28.62% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 603367 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥2.24 Billion

≈ $328.13 Million USD Cash + Short-term Investments

Total Assets

CN¥7.83 Billion

≈ $1.15 Billion USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Cisen Pharmaceutical Co Ltd (2015–2025)

Asset resilience ratio of Cisen Pharmaceutical Co Ltd from 2015 to 2025. This chart shows how Cisen Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read 603367 liabilities breakdown for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Cisen Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Cisen Pharmaceutical Co Ltd balance sheet assets.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥2.24 Billion	28.62%
Total Liquid Assets	CN¥2.24 Billion	28.62%

Asset Resilience Insights

Very High Liquidity: Cisen Pharmaceutical Co Ltd maintains exceptional liquid asset reserves at 28.62% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Cisen Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Cisen Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Drug Manufacturers - Specialty & Generic	0.20%
Emcure Pharmaceuticals Ltd NSE:EMCURE	Drug Manufacturers - Specialty & Generic	1.38%
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	Drug Manufacturers - Specialty & Generic	9.04%
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	Drug Manufacturers - Specialty & Generic	29.37%
Ajanta Pharma Limited NSE:AJANTPHARM	Drug Manufacturers - Specialty & Generic	14.99%
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	Drug Manufacturers - Specialty & Generic	1.01%
Luoxin Pharmaceuticals Group Stock Co Ltd SHE:002793	Drug Manufacturers - Specialty & Generic	0.17%
Shaanxi Kanghui Pharm Co Ltd SHG:603139	Drug Manufacturers - Specialty & Generic	0.01%

Cisen Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2015–2025)

Cisen Pharmaceutical Co Ltd asset resilience ratio by year from 2015 to 2025. The table below shows the annual Asset Resilience Ratio data for Cisen Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	22.77%	CN¥1.73 Billion ≈ $253.13 Million	CN¥7.60 Billion ≈ $1.11 Billion	+5.89pp
2024-12-31	16.88%	CN¥1.28 Billion ≈ $186.58 Million	CN¥7.55 Billion ≈ $1.11 Billion	-5.44pp
2023-12-31	22.32%	CN¥1.64 Billion ≈ $239.64 Million	CN¥7.34 Billion ≈ $1.07 Billion	-0.42pp
2022-12-31	22.74%	CN¥1.55 Billion ≈ $226.77 Million	CN¥6.82 Billion ≈ $997.26 Million	-0.59pp
2021-12-31	23.33%	CN¥1.48 Billion ≈ $217.25 Million	CN¥6.36 Billion ≈ $931.21 Million	-7.08pp
2020-12-31	30.41%	CN¥1.88 Billion ≈ $274.41 Million	CN¥6.17 Billion ≈ $902.24 Million	-5.30pp
2019-12-31	35.72%	CN¥1.98 Billion ≈ $289.24 Million	CN¥5.53 Billion ≈ $809.76 Million	+35.45pp
2018-12-31	0.27%	CN¥14.33 Million ≈ $2.10 Million	CN¥5.25 Billion ≈ $768.00 Million	-0.15pp
2017-12-31	0.42%	CN¥20.00 Million ≈ $2.93 Million	CN¥4.74 Billion ≈ $693.89 Million	-3.24pp
2016-12-31	3.66%	CN¥120.00 Million ≈ $17.56 Million	CN¥3.28 Billion ≈ $480.08 Million	+1.68pp
2015-12-31	1.98%	CN¥60.00 Million ≈ $8.78 Million	CN¥3.03 Billion ≈ $443.97 Million	--

pp = percentage points

About Cisen Pharmaceutical Co Ltd

SHG:603367 China Drug Manufacturers - Specialty & Generic

Market Cap

$879.17 Million

CN¥6.01 Billion CNY

Market Cap Rank

#9151 Global

#2231 in China

Share Price

CN¥13.27

Change (1 day)

-1.19%

52-Week Range

CN¥12.45 - CN¥21.62

All Time High

CN¥34.05